Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors

Journal of the American College of Cardiology
Weijuan LiJavid Moslehi

Abstract

Novel targeted cancer therapies, especially kinase inhibitors, have revolutionized the treatment of many cancers and have dramatically improved the survival of several types of malignancies. Because kinases not only are important in cancer development and progression, but also play a critical role in the cardiovascular (CV) system and metabolic homeostasis, important CV and metabolic sequelae have been associated with several types of kinase inhibitors. This paper reviews the incidences and highlights potential mechanisms of vascular and metabolic perturbations associated with 3 classes of commonly used kinase inhibitors that target the vascular endothelial growth factor signaling pathway, the ABL kinase, and the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin signaling pathway. We propose preventive, screening, monitoring, and management strategies for CV care of patients treated with these novel agents.

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Jun 28, 1995·JAMA : the Journal of the American Medical Association·T M GuestA S Jaffe
Oct 3, 2002·Nature Reviews. Cancer·Napoleone Ferrara
Aug 2, 2003·The New England Journal of Medicine·James C YangSteven A Rosenberg
Dec 17, 2004·Pharmacological Reviews·Ann HoebenErnst A De Bruijn
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Sep 30, 2005·The New England Journal of Medicine·Hossein A GhofraniFriedrich Grimminger
Dec 16, 2005·Nature·Napoleone Ferrara, Robert S Kerbel
Dec 21, 2005·Journal of Cellular and Molecular Medicine·Anne Marie ByrneJ H Harmey
Jan 27, 2006·Journal of the American Society of Nephrology : JASN·Vera EreminaSusan E Quaggin
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Cullen M TaniguchiC Ronald Kahn
Apr 4, 2007·Cell Cycle·Julie R McMullen, Patrick Y Jay
May 2, 2007·Circulation·Donald E CutlipUNKNOWN Academic Research Consortium
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Aug 10, 2007·Journal of the National Cancer Institute·Frank A ScappaticciHerbert Hurwitz
Jan 4, 2008·The New England Journal of Medicine·Michel AziziStéphane Oudard
Mar 14, 2008·The New England Journal of Medicine·Vera EreminaSusan E Quaggin
Nov 6, 2008·Journal of Thrombosis and Haemostasis : JTH·T MeyerA Amirkhosravi
Nov 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cédric LouvetJeffrey A Bluestone
Nov 20, 2008·JAMA : the Journal of the American Medical Association·Shobha Rani NalluriShenhong Wu
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Jun 3, 2009·Current Vascular Pharmacology·Patrizia FerroniFiorella Guadagni
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael L MaitlandMark J Ratain
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriJoaquim Bellmunt
Mar 31, 2010·Journal of the National Cancer Institute·Michael L MaitlandUNKNOWN Cardiovascular Toxicities Panel, Convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Dr
Apr 10, 2010·Nature Reviews. Molecular Cell Biology·Bart VanhaesebroeckBenoit Bilanges
Jun 8, 2010·The New England Journal of Medicine·Giuseppe SaglioUNKNOWN ENESTnd Investigators
Aug 6, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Nicole M AgostinoJoseph J Drabick
Sep 24, 2010·American Journal of Physiology. Cell Physiology·Xiaoxiao SongTakashi Matsui

❮ Previous
Next ❯

Citations

Apr 9, 2016·Indian Heart Journal·Richard M Cubbon, Alexander R Lyon
Jun 9, 2016·The Journal of Clinical Investigation·Suzanne D BurkeS Ananth Karumanchi
Feb 27, 2016·CA: a Cancer Journal for Clinicians·Giuseppe CuriglianoCarlo Maria Cipolla
Oct 13, 2016·The New England Journal of Medicine·Javid J Moslehi
Apr 4, 2017·International Journal of Cardiology·Ludovic JovenauxFranck Thuny
Oct 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Peter GálKarel Smetana
Dec 5, 2017·Applied Biochemistry and Biotechnology·Maryam Honardoost, Seyed Mohammad Ali Hosseini Rad
Nov 28, 2017·Clinical and Experimental Hypertension : CHE·Amber KemptonSakima A Smith
Jun 7, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianLeontien C M Kremer
Aug 22, 2018·Expert Opinion on Drug Safety·Antonis A ManolisAntonis S Manolis
Aug 22, 2018·Expert Opinion on Drug Safety·Antonis A ManolisAntonis S Manolis
Feb 6, 2018·F1000Research·Timothy M Markman, Maurie Markman
Feb 16, 2019·Cardiovascular Research·Nazish SayedJoseph C Wu
Jun 5, 2019·International Journal of Molecular Sciences·MacRae F LintonVladimir R Babaev
Sep 11, 2016·Clinical Science·Srila GopalIris Z Jaffe
Mar 9, 2019·Cardiac Failure Review·Martin NicolAlain Cohen-Solal
Jun 11, 2019·Cardiac Failure Review·Edoardo BerteroChristoph Maack
Mar 14, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Ozgur TanriverdiAli Alkan
May 15, 2018·Oncotarget·Jolanta MałyszkoJacek Małyszko
Sep 5, 2020·Journal of Thrombosis and Thrombolysis·Wendy BottinorEiman Jahangir
Dec 15, 2015·European Journal of Heart Failure·Muthiah Vaduganathan, Vinay Prasad
Feb 23, 2020·Current Hematologic Malignancy Reports·Dakota GustafsonNazanin Aghel
Jul 22, 2020·Cardio-Oncology·Diego SadlerZeina Nahleh
Mar 5, 2016·Current Treatment Options in Cardiovascular Medicine·Bryan J BrindaMichael G Fradley
May 23, 2017·Japanese Journal of Clinical Oncology·Kazuko TajiriIkuo Sekine
Aug 11, 2017·Medical Oncology·David Pérez-CallejoMariano Provencio
May 1, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·Cody N JusticeSakima A Smith
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Anne H BlaesJavid Moslehi
Aug 7, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Crystal S DenlingerDeborah A Freedman-Cass

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Chinese Journal of Cancer
Khurum H KhanDavid Cunningham
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Josiah D LandNizar M Tannir
Journal of the Advanced Practitioner in Oncology
Laura Bourdeanu, Thehan Luu
© 2021 Meta ULC. All rights reserved